Blair William & Co. IL Has $2.67 Million Stake in Agilent Technologies, Inc. (NYSE:A)

Blair William & Co. IL boosted its holdings in shares of Agilent Technologies, Inc. (NYSE:A) by 5.0% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 20,560 shares of the medical research company’s stock after buying an additional 985 shares during the period. Blair William & Co. IL’s holdings in Agilent Technologies were worth $2,665,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently bought and sold shares of A. Livelsberger Financial Advisory acquired a new position in shares of Agilent Technologies in the 4th quarter worth approximately $26,000. Crewe Advisors LLC raised its stake in Agilent Technologies by 114.8% during the second quarter. Crewe Advisors LLC now owns 189 shares of the medical research company’s stock worth $25,000 after acquiring an additional 101 shares in the last quarter. Ridgewood Investments LLC bought a new position in shares of Agilent Technologies during the second quarter valued at $29,000. Rise Advisors LLC boosted its stake in shares of Agilent Technologies by 527.8% in the 1st quarter. Rise Advisors LLC now owns 226 shares of the medical research company’s stock valued at $33,000 after purchasing an additional 190 shares in the last quarter. Finally, YHB Investment Advisors Inc. bought a new stake in shares of Agilent Technologies in the 1st quarter worth about $34,000. Institutional investors own 87.42% of the company’s stock.

Insider Activity

In related news, CEO Padraig Mcdonnell sold 1,958 shares of the business’s stock in a transaction on Thursday, August 22nd. The shares were sold at an average price of $145.00, for a total value of $283,910.00. Following the sale, the chief executive officer now directly owns 24,118 shares of the company’s stock, valued at approximately $3,497,110. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. 0.33% of the stock is currently owned by company insiders.

Agilent Technologies Stock Down 1.3 %

Shares of NYSE:A opened at $140.09 on Monday. The company has a debt-to-equity ratio of 0.36, a current ratio of 1.78 and a quick ratio of 1.37. The stock has a market cap of $40.87 billion, a price-to-earnings ratio of 33.12, a P/E/G ratio of 6.43 and a beta of 1.05. The company has a 50 day moving average of $137.87 and a 200-day moving average of $139.16. Agilent Technologies, Inc. has a one year low of $96.80 and a one year high of $155.35.

Agilent Technologies (NYSE:A) last issued its earnings results on Wednesday, August 21st. The medical research company reported $1.32 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.26 by $0.06. The firm had revenue of $1.58 billion for the quarter, compared to analysts’ expectations of $1.56 billion. Agilent Technologies had a return on equity of 25.26% and a net margin of 21.75%. The company’s revenue was down 5.6% compared to the same quarter last year. During the same quarter last year, the business earned $1.43 earnings per share. On average, sell-side analysts forecast that Agilent Technologies, Inc. will post 5.24 earnings per share for the current year.

Agilent Technologies Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, October 23rd. Stockholders of record on Tuesday, October 1st will be given a dividend of $0.236 per share. This represents a $0.94 dividend on an annualized basis and a dividend yield of 0.67%. The ex-dividend date of this dividend is Tuesday, October 1st. Agilent Technologies’s dividend payout ratio is currently 22.22%.

Analyst Upgrades and Downgrades

A has been the subject of several analyst reports. Jefferies Financial Group reissued a “hold” rating and set a $135.00 price target (down from $152.00) on shares of Agilent Technologies in a report on Monday, June 3rd. UBS Group increased their price target on Agilent Technologies from $141.00 to $150.00 and gave the stock a “neutral” rating in a research report on Thursday, August 22nd. TD Cowen raised their price target on Agilent Technologies from $153.00 to $160.00 and gave the company a “buy” rating in a report on Thursday, August 22nd. Robert W. Baird reduced their price objective on Agilent Technologies from $147.00 to $136.00 and set an “outperform” rating on the stock in a research note on Thursday, May 30th. Finally, Evercore ISI raised their target price on Agilent Technologies from $130.00 to $135.00 and gave the company an “in-line” rating in a research note on Thursday, August 22nd. One research analyst has rated the stock with a sell rating, six have assigned a hold rating and nine have issued a buy rating to the company’s stock. According to MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $141.60.

About Agilent Technologies

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.